Moderna Inc (MRNA)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Net income (ttm)	US$ in thousands	-4,714,000	-3,466,000	1,207,000	4,784,000	8,362,000	11,765,000	14,055,000	14,638,000	12,202,000	7,061,000	3,495,000	598,000	-747,000	-597,269	-487,484	-505,424	-514,000	-532,123
Revenue (ttm)	US$ in thousands	6,758,000	9,088,000	10,654,000	15,059,000	19,263,000	21,390,000	22,995,000	22,600,000	18,471,000	11,831,000	7,019,000	2,732,000	803,000	246,055	106,101	52,184	60,209	81,575
Net profit margin		-69.75%	-38.14%	11.33%	31.77%	43.41%	55.00%	61.12%	64.77%	66.06%	59.68%	49.79%	21.89%	-93.03%	-242.74%	-459.45%	-968.54%	-853.69%	-652.31%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-4,714,000K ÷ $6,758,000K
= -69.75%

The net profit margin of Moderna Inc has shown significant fluctuations over the past eight quarters. In Q4 2023, the net profit margin was -68.84%, reflecting a substantial loss relative to revenue. This was a notable decline from the previous quarter's net profit margin of -38.00%. Prior to that, the net profit margin had improved to 11.33% in Q2 2023 and further increased to 31.77% in Q1 2023, although it had not reached the level seen in the same quarter of the previous year (Q1 2022) which stood at 64.77%.

The trend over the past year indicates a decrease in profitability compared to the corresponding periods in the previous year. There was a steady decline from Q1 2022 to Q4 2023, highlighting challenges in maintaining profitability levels. The sharp fluctuations in net profit margin suggest that Moderna Inc's financial performance has been volatile and subject to various factors impacting its profitability.

Further analysis and investigation into the company's financial and operational aspects would be necessary to understand the underlying reasons for these fluctuations in net profit margin and to assess the company's overall financial health and sustainability.